Aims Worldwide observational studies are evidencing discordance between guidelines and
real‐world practice regarding direct oral anticoagulant drug (DOAC) doses. This systematic …

Stroke and venous thromboembolism continues to be a major cause of morbidity and
mortality worldwide. The use of anticoagulation therapy has proven effective in the …

Background and Objectives: Appropriate dosing of direct oral anticoagulants (DOACs) is
required to avoid under-and overdosing that may precipitate strokes or thromboembolic …

Introduction and objectives To assess the effectiveness of direct oral anticoagulants vs
vitamin K antagonists in real-life patients with atrial fibrillation. Methods A systematic review …

Background We evaluated adherence to dosing criteria for patients with atrial fibrillation (AF)
taking dabigatran or rivaroxaban and the impact of off-label dosing on thromboembolic and …

Background: The aim of this study was to investigate the frequency of oral anticoagulant
drugs and time in therapeutic range in patients receiving warfarin in addition to the …

Purpose This study aimed to estimate the prevalence, contributory factors, and severity of
medication errors associated with direct acting oral anticoagulants (DOACs). Methods A …

Aims A Markov model was adapted to assess the real-world cost-effectiveness of
rivaroxaban, dabigatran and apixaban. Each of these non-vitamin K antagonist oral …

Objectives: To describe the sex and gender differences in the treatment initiation and in the
socio-demographic and clinical characteristics of all patients initiating an oral anticoagulant …

What is known and objective The complex dose regimens of the direct‐acting oral
anticoagulants (DOAC) make their appropriate prescribing highly challenging. Inappropriate …